2m 2m 2m 2m 2m 2m 2m
Diagnos (DGNOF)
OTC
$0.27-$0.007 (-2.41%)
Price as of Aug 21, 2026- N/AMarket Cap
- 45.24%1-Year Change
- Health Information ServicesIndustry
Diagnos (DGNOF)
$0.27-$0.007 (-2.41%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.27
$0.28
$0.27
1-Year Range
$0.13
$0.29
$0.27
Latest Close$0.27
Change
-$0.007 (-2.47%)
Volume44,175
Information as of 08/21/2026
Company Profile
Diagnos Inc.
https://diagnosmedical.comN/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Health Information Services
7005 Taschereau Boulevard, Brossard, QC, Canada, J4Z 1A7
450 678 8882DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.
Key Executives
- Andre Larente
- Marc-André Massue
- Yves-Stéphane Couture
- Ismail Ben Ayed
Current Ownership Distribution
- Other120.4M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)